You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Routine Long-term Follow-up in Patients Treated With Curative Intent for Squamous Cell Carcinoma of the Larynx, Pharynx, and Oral Cavity

Does It Make Sense?

Anthony V. M. de Visscher, MD; Johannes J. Manni, MD, PhD

Arch Otolaryngol Head Neck Surg. 1994;120(9):934-939.


Abstract

Objective
To evaluate whether additional curative treatment was possible in patients for whom routine long-term follow-up had led to the early detection of locoregional recurrence, distant metastases, and second primary tumors (events).

Design
Cohort study with a maximum follow-up of 126 months and a consensus questionnaire.

Setting
Department of Head and Neck Oncology at the University Hospital Nijmegen (the Netherlands).

Patients
There were 428 patients treated with curative intent for carcinoma of the larynx, pharynx, and oral cavity from 1979 to 1983.

Main Outcome Measures
Site, stage, differentiation grade, and type of treatment of index tumor (routine follow-up vs self-referral).

Results
There were 205 patients (47.9%) who developed events, 76.1% within 3 years of initial treatment. Eighty-nine patients (43.4%) received curative treatment. The detection rate for events during routine follow-up (6350 appointments) was one in 34, and for self-referrals (54) it was one in 2.7; the cure rates were one in 78 and one in 6.8, respectively. The mean survival after detection of events with routine follow-up was significantly (P<.05) better than with self-referral (58 vs 32 months, respectively).

Conclusions
Routine follow-up is indispensible. Site and stage of the index tumor played a part in the length of routine follow-up, in contrast to the differentiation grade or type of initial treatment. Yearly chest roentgenograms were valuable only for laryngeal index tumors. Patients considered routine follow-up important; however, negative findings at physical examination of complaints did not reassure all patients.

(Arch Otolaryngol Head Neck Surg. 1994;120:934-939)



Author Affiliations

From the Department of Otorhinolaryngology–Head and Neck Surgery, University Hospital Nijmegen (the Netherlands). Dr Manni is now with the Department of Otorhinolaryngology–Head and Neck Surgery, Academic Hospital Maastricht (the Netherlands). Dr de Visscher is now with the Academic Hospital Groningen (the Netherlands).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biological Markers and Prognosis in Recurrent Oral Cancer After Salvage Surgery
Agra et al.
Arch Otolaryngol Head Neck Surg 2008;134:743-749.
ABSTRACT | FULL TEXT  

Symptom-Directed Selective Endoscopy: Long-term Efficacy
Benninger et al.
Arch Otolaryngol Head Neck Surg 2001;127:770-773.
ABSTRACT | FULL TEXT  

Is Routine Follow-up Useful After Combined-Modality Therapy for Advanced Head and Neck Cancer?
Cooney and Poulsen
Arch Otolaryngol Head Neck Surg 1999;125:379-382.
ABSTRACT | FULL TEXT  

Practice Patterns and Clinical Guidelines for Posttreatment Follow-up of Head and Neck Cancers: A Comparison of 2 Professional Societies
Paniello et al.
Arch Otolaryngol Head Neck Surg 1999;125:309-313.
ABSTRACT | FULL TEXT  

Costs of Posttreatment Surveillance for Patients With Upper Aerodigestive Tract Cancer
Virgo et al.
Arch Otolaryngol Head Neck Surg 1998;124:564-572.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.